CN102731512A - 一种鲁拉西酮中间体及鲁拉西酮的制备方法 - Google Patents
一种鲁拉西酮中间体及鲁拉西酮的制备方法 Download PDFInfo
- Publication number
- CN102731512A CN102731512A CN2011100915280A CN201110091528A CN102731512A CN 102731512 A CN102731512 A CN 102731512A CN 2011100915280 A CN2011100915280 A CN 2011100915280A CN 201110091528 A CN201110091528 A CN 201110091528A CN 102731512 A CN102731512 A CN 102731512A
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- wormwood
- salt
- binding agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- PQXKDMSYBGKCJA-CVTJIBDQSA-N lurasidone Chemical compound C1=CC=C2C(N3CCN(CC3)C[C@@H]3CCCC[C@H]3CN3C(=O)[C@@H]4[C@H]5CC[C@H](C5)[C@@H]4C3=O)=NSC2=C1 PQXKDMSYBGKCJA-CVTJIBDQSA-N 0.000 title abstract description 7
- 229960001432 lurasidone Drugs 0.000 title abstract description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 56
- 238000010992 reflux Methods 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000002253 acid Substances 0.000 claims abstract description 10
- 239000011230 binding agent Substances 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims abstract description 8
- 239000003444 phase transfer catalyst Substances 0.000 claims abstract description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 22
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 21
- 235000015320 potassium carbonate Nutrition 0.000 claims description 21
- 150000002576 ketones Chemical class 0.000 claims description 18
- 235000017550 sodium carbonate Nutrition 0.000 claims description 11
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 11
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 claims description 6
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical group [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 4
- AJSHDAOMUKXVDC-UHFFFAOYSA-N butan-1-amine;sulfuric acid Chemical compound CCCC[NH3+].OS([O-])(=O)=O AJSHDAOMUKXVDC-UHFFFAOYSA-N 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 23
- 238000004440 column chromatography Methods 0.000 abstract description 5
- 230000035484 reaction time Effects 0.000 abstract description 3
- 238000010438 heat treatment Methods 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 150000003892 tartrate salts Chemical class 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 60
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 239000002994 raw material Substances 0.000 description 12
- 238000005160 1H NMR spectroscopy Methods 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 238000000227 grinding Methods 0.000 description 8
- 238000001914 filtration Methods 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 229940095064 tartrate Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- YSSSPARMOAYJTE-UHFFFAOYSA-N dibenzo-18-crown-6 Chemical compound O1CCOCCOC2=CC=CC=C2OCCOCCOC2=CC=CC=C21 YSSSPARMOAYJTE-UHFFFAOYSA-N 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 101150049660 DRD2 gene Proteins 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Images
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
碳酸钾平均粒径 | 式(Ⅱ)化合物收率 | 式(Ⅱ)化合物熔点 |
350 | 40% | 220~225℃ |
245 | 55% | 222~226℃ |
220 | 65% | 223~227℃ |
198 | 75% | 228~230℃ |
165 | 76% | 228.5~230.5℃ |
74 | 78% | 228~229℃ |
碳酸钾平均粒径 | 式(Ⅰ)-消旋体收率 | 式(Ⅰ)-消旋体熔点 |
350 | 70% | 215~217℃ |
245 | 75% | 216~218℃ |
220 | 80% | 218~220℃ |
198 | 91% | 225~227℃ |
165 | 92% | 226~228℃ |
74 | 92.5% | 225.5~228℃ |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110091528.0A CN102731512B (zh) | 2011-04-12 | 2011-04-12 | 一种鲁拉西酮中间体及鲁拉西酮的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110091528.0A CN102731512B (zh) | 2011-04-12 | 2011-04-12 | 一种鲁拉西酮中间体及鲁拉西酮的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102731512A true CN102731512A (zh) | 2012-10-17 |
CN102731512B CN102731512B (zh) | 2015-04-22 |
Family
ID=46987889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110091528.0A Expired - Fee Related CN102731512B (zh) | 2011-04-12 | 2011-04-12 | 一种鲁拉西酮中间体及鲁拉西酮的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102731512B (zh) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102936243A (zh) * | 2012-11-16 | 2013-02-20 | 上海伯倚化工科技有限公司 | 一种鲁拉西酮的合成方法 |
CN103207246A (zh) * | 2012-12-21 | 2013-07-17 | 北京万全德众医药生物技术有限公司 | 一种用液相色谱法分离测定鲁拉西酮及其光学异构体的方法 |
WO2014064714A2 (en) * | 2012-10-22 | 2014-05-01 | Glenmark Pharmaceuticals Limited; Glenmark Generics Limited | Process for preparation of lurasidone hydrochloride |
CN103864774A (zh) * | 2012-12-14 | 2014-06-18 | 成都弘达药业有限公司 | 一种鲁拉西酮的制备方法 |
ITMI20130262A1 (it) * | 2013-02-22 | 2014-08-23 | Edmond Pharma Srl | Procedimento per la preparazione di lurasidone cloridrato |
WO2016059649A1 (en) * | 2014-10-14 | 2016-04-21 | Jubilant Generics Limited (Formerly Jubilant Life Sciences Division) | An improved process for the preparation of lurasidone hydrochloride |
CN106146486A (zh) * | 2015-04-21 | 2016-11-23 | 上海医药集团股份有限公司 | 一种制备高纯度高收率鲁拉西酮的方法 |
CN106632358A (zh) * | 2016-10-31 | 2017-05-10 | 北京万全德众医药生物技术有限公司 | 盐酸鲁拉西酮中间体的一种制备方法 |
CN106946872A (zh) * | 2017-03-20 | 2017-07-14 | 常州工程职业技术学院 | 一种制备鲁拉西酮关键中间体的方法 |
CN108430982A (zh) * | 2015-12-25 | 2018-08-21 | 盐野义制药株式会社 | 用于制备噻嗪衍生物的方法和中间体 |
US10196400B2 (en) | 2015-01-08 | 2019-02-05 | Piramal Enterprises Limited | Process for the preparation of lurasidone and its intermediate |
CN113185507A (zh) * | 2020-01-14 | 2021-07-30 | 扬子江药业集团南京海陵药业有限公司 | 一种鲁拉西酮制备方法 |
CN115950695A (zh) * | 2021-10-09 | 2023-04-11 | 北京阳光诺和药物研究股份有限公司 | 一种制备鲁拉西酮基毒杂质的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0464846A1 (en) * | 1990-07-06 | 1992-01-08 | Sumitomo Pharmaceuticals Company, Limited | Imide derivatives, and their production and use |
WO1996014297A1 (fr) * | 1994-11-04 | 1996-05-17 | Sumitomo Pharmaceuticals Company, Limited | Nouveaux derives de lactame |
JP2006169155A (ja) * | 2004-12-15 | 2006-06-29 | Sumitomo Chemical Co Ltd | 第四級アンモニウム塩の製造法 |
CN101146539A (zh) * | 2005-03-01 | 2008-03-19 | 辉瑞有限公司 | Pde7抑制剂用于治疗神经性疼痛的用途 |
-
2011
- 2011-04-12 CN CN201110091528.0A patent/CN102731512B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0464846A1 (en) * | 1990-07-06 | 1992-01-08 | Sumitomo Pharmaceuticals Company, Limited | Imide derivatives, and their production and use |
WO1996014297A1 (fr) * | 1994-11-04 | 1996-05-17 | Sumitomo Pharmaceuticals Company, Limited | Nouveaux derives de lactame |
JP2006169155A (ja) * | 2004-12-15 | 2006-06-29 | Sumitomo Chemical Co Ltd | 第四級アンモニウム塩の製造法 |
CN101146539A (zh) * | 2005-03-01 | 2008-03-19 | 辉瑞有限公司 | Pde7抑制剂用于治疗神经性疼痛的用途 |
Non-Patent Citations (2)
Title |
---|
CHARLES M. MARSON,等: "Enantioselective Syntheses of trans-3,4-Difluoropyrrolidines and Investigation of Their Applications in Catalytic Asymmetric Synthesis", 《JOURNAL OF ORGANIC CHEMISTRY》 * |
CHARLES M. MARSON,等: "Synthesis of (3S,3S’,4S,4S’)-1,1’-ethylene-di-pyrrolidine-3,3’,4,4’-tetraol and related diamino diols: donor-acceptor hydrogen-bonding motifs of the C2 symmetric 3,4-dihydroxypyrrolidine unit", 《TETRAHEDRON: ASYMMETRY》 * |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014064714A2 (en) * | 2012-10-22 | 2014-05-01 | Glenmark Pharmaceuticals Limited; Glenmark Generics Limited | Process for preparation of lurasidone hydrochloride |
WO2014064714A3 (en) * | 2012-10-22 | 2014-06-05 | Glenmark Pharmaceuticals Limited; Glenmark Generics Limited | Process for preparation of lurasidone hydrochloride |
CN102936243B (zh) * | 2012-11-16 | 2015-08-05 | 上海伯倚化工科技有限公司 | 一种鲁拉西酮的合成方法 |
CN102936243A (zh) * | 2012-11-16 | 2013-02-20 | 上海伯倚化工科技有限公司 | 一种鲁拉西酮的合成方法 |
CN103864774A (zh) * | 2012-12-14 | 2014-06-18 | 成都弘达药业有限公司 | 一种鲁拉西酮的制备方法 |
CN103864774B (zh) * | 2012-12-14 | 2016-09-28 | 成都弘达药业有限公司 | 一种鲁拉西酮的制备方法 |
CN103207246B (zh) * | 2012-12-21 | 2017-10-10 | 北京万全德众医药生物技术有限公司 | 一种用液相色谱法分离测定鲁拉西酮及其光学异构体的方法 |
CN103207246A (zh) * | 2012-12-21 | 2013-07-17 | 北京万全德众医药生物技术有限公司 | 一种用液相色谱法分离测定鲁拉西酮及其光学异构体的方法 |
ITMI20130262A1 (it) * | 2013-02-22 | 2014-08-23 | Edmond Pharma Srl | Procedimento per la preparazione di lurasidone cloridrato |
US10426770B2 (en) | 2014-10-14 | 2019-10-01 | Jubilant Generics Limited | Process for the preparation of Lurasidone hydrochloride |
WO2016059649A1 (en) * | 2014-10-14 | 2016-04-21 | Jubilant Generics Limited (Formerly Jubilant Life Sciences Division) | An improved process for the preparation of lurasidone hydrochloride |
US10196400B2 (en) | 2015-01-08 | 2019-02-05 | Piramal Enterprises Limited | Process for the preparation of lurasidone and its intermediate |
CN106146486A (zh) * | 2015-04-21 | 2016-11-23 | 上海医药集团股份有限公司 | 一种制备高纯度高收率鲁拉西酮的方法 |
CN113185508A (zh) * | 2015-04-21 | 2021-07-30 | 上海医药集团股份有限公司 | 一种制备高纯度高收率鲁拉西酮的方法 |
CN108430982A (zh) * | 2015-12-25 | 2018-08-21 | 盐野义制药株式会社 | 用于制备噻嗪衍生物的方法和中间体 |
CN106632358A (zh) * | 2016-10-31 | 2017-05-10 | 北京万全德众医药生物技术有限公司 | 盐酸鲁拉西酮中间体的一种制备方法 |
CN106946872A (zh) * | 2017-03-20 | 2017-07-14 | 常州工程职业技术学院 | 一种制备鲁拉西酮关键中间体的方法 |
CN113185507A (zh) * | 2020-01-14 | 2021-07-30 | 扬子江药业集团南京海陵药业有限公司 | 一种鲁拉西酮制备方法 |
CN113185507B (zh) * | 2020-01-14 | 2022-07-26 | 扬子江药业集团南京海陵药业有限公司 | 一种鲁拉西酮制备方法 |
CN115950695A (zh) * | 2021-10-09 | 2023-04-11 | 北京阳光诺和药物研究股份有限公司 | 一种制备鲁拉西酮基毒杂质的方法 |
CN115950695B (zh) * | 2021-10-09 | 2023-07-28 | 北京阳光诺和药物研究股份有限公司 | 一种制备鲁拉西酮基毒杂质的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102731512B (zh) | 2015-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102731512A (zh) | 一种鲁拉西酮中间体及鲁拉西酮的制备方法 | |
CN101386605B (zh) | 非布司他新型晶体及其制备方法 | |
CN103694175A (zh) | 一种制备盐酸右美托咪定的新方法 | |
CN101891676A (zh) | 一种新的5-甲基-1-苯基-2-(1h)-吡啶酮的制备方法 | |
CN101560183B (zh) | 5-溴-2-甲基吡啶的制备方法 | |
CN101343241A (zh) | 磷酸奥司他韦的纯化方法 | |
CN103641836A (zh) | 2-甲基三乙烯二胺的制备方法 | |
CN103804232B (zh) | 一种1-氰基-1-(7-甲氧基-3,4-二氢-1-萘基)甲醇酯类化合物及其制备方法和应用 | |
CN102659605B (zh) | 一种亚精胺的合成方法 | |
CN101318140A (zh) | 一种甘油脱水直接生成丙烯醛的新催化剂及制法和用法 | |
CN104744530B (zh) | 一种天麻衍生物晶型及其制备方法、制剂与应用 | |
CN102336710B (zh) | 一种依达拉奉衍生物的合成方法 | |
CN103304524A (zh) | 一种雷美替胺中间体的制备方法 | |
CN102941119A (zh) | 一种二氧化硅负载杂多酸铯催化剂的制备方法 | |
CN102659629A (zh) | 化合物及其在制备埃罗替尼中的用途 | |
CN105884746B (zh) | 氟马替尼的合成方法 | |
CN104276979B (zh) | 阿戈美拉汀中间体的制备方法 | |
CN102731265B (zh) | 一种高纯度丙泊酚的制备方法 | |
CN102199146A (zh) | 制备n-(5-氨基-2-甲基苯基)-4-(3-吡啶基)-2-嘧啶胺的方法 | |
CN114685349A (zh) | 顺-外-二环[2.2.1]庚烷-2,3-二甲酰亚胺的制备方法 | |
CN113980012A (zh) | 恩曲他滨的纯化方法 | |
CN104496939A (zh) | 一种催化加氢制备哌嗪或烷基哌嗪的方法 | |
CN115286629B (zh) | 一种催化制备医药中间体3-苯氨基咪唑[1,2-a]吡啶衍生物的方法 | |
CN100448836C (zh) | 一种抗艾滋病药物关键中间体的制备方法 | |
CN104355954B (zh) | 一种制备四氢萘胺类化合物的工艺方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee after: Tianjin Institute of Pharmaceutical Research Co.,Ltd. Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee before: Tianjin Institute of Pharmaceutical Research |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200518 Address after: 300462 No.101, Xinye 8th Street, economic and Technological Development Zone, Binhai New Area, Tianjin Patentee after: TIANJIN TAIPU PHARMACEUTICAL Co.,Ltd. Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee before: Tianjin Institute of Pharmaceutical Research Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150422 |
|
CF01 | Termination of patent right due to non-payment of annual fee |